Candel Therapeutics CADL
NASDAQ CADL
$9.35 -0.14 (-1.48%)
At close: Nov 10, 2026 · 4:00 PM EST

Candel Therapeutics (CADL) Revenue (2020 - 2023)

Updated

Analysis

Candel Therapeutics (CADL) Revenue (2020 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 24.40 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 25.40 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 17.40 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 18.09 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 15.07 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 10.37 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 8.30 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 16.58 Bn
10 Candel Therapeutics 711.71 Mn 108.61 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 102,000.00
Dec 31, 2022 31,000.00
Sep 30, 2022 31,000.00
Jun 30, 2022 31,000.00
Mar 31, 2022 31,000.00
Dec 31, 2021 31,000.00
Sep 30, 2021 31,000.00
Jun 30, 2021 31,000.00
Mar 31, 2021 31,000.00
Dec 31, 2020 31,000.00
Sep 30, 2020 31,000.00
Jun 30, 2020 31,000.00
API Access

Candel Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=CADL&period=max&api_key=YOUR_API_KEY